This study is not yet accepting patients
A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California
- Dates
- study startedestimated completion
- Principal Investigator
- by Nicholas Butowski, MD
Description
Summary
Official Title
Keywords
Eligibility
Location
Lead Scientist at UCSF
- Nicholas Butowski, MD
Dr. Nicholas Butowski is a neuro-oncologist who specializes in brain tumors, neuroimaging, cognitive and rehabilitative neurology, and complementary therapies for neurological disorders. He is director of clinical services in neuro-oncology and a researcher at the Brain Tumor Center.
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Mclean Hospital
- ID
- NCT05753007
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 36 study participants
- Last Updated